| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.7M | +18.8% |
| Cost of Revenue | $39.4M | +28.6% |
| Gross Profit | $15.3M | -0.7% |
| R&D Expense | $500K | +0.0% |
| SG&A Expense | $32.5M | +13.9% |
| Operating Income | -$38.8M | -124.5% |
| Pre-tax Income | -$39.3M | -1248.8% |
| Income Tax | -$18K | -148.6% |
| Net Income | -$39.3M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | -85.4% |
| Accounts Receivable | $6.7M | -0.7% |
| Inventory | $10.3M | +95.6% |
| Current Assets | $27.5M | -37.3% |
| Total Assets | $38.7M | -48.2% |
| Current Liabilities | $5.6M | -24.0% |
| Long-term Debt | $11.4M | +11.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.6M | -73.3% |
| Capital Expenditures | $198K | -43.9% |
| Investing Cash Flow | -$198K | +43.9% |
| Financing Cash Flow | $1.3M | -96.6% |
| Free Cash Flow | -$20.8M | -69.9% |
| -1260.8% |
| EPS (Basic) | -$1.34 | -993.3% |
| EPS (Diluted) | -$1.34 | -1057.1% |
| Total Liabilities |
| $17.1M |
| +2.2% |
| Stockholders' Equity | $21.5M | -62.8% |